NVIDIA Launches $1 Billion AI Drug Discovery Lab with Lilly, Expands BioNeMo Platform
NVIDIA launches a $1 billion AI drug discovery lab with pharmaceutical giant Lilly and expands its BioNeMo platform, partnering with major life sciences companies to automate scientific discovery through AI models that predict molecular structures and connect digital agents to robotic laboratory systems.